 If approved, this would be one more tool in the fight against obesity. Pfizer announcing it has selected a formula for its once-a-day GLP-1 receptor weight loss pill. The pill's intent is to act similarly as those weekly shots like Wegovi and Zetbound that suppress appetite and lower food intake. ABC's Ariel Reshef.